Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Not yet recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 88Neoplasm Metastasis 8Stomach Neoplasms 5Colorectal Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Brain Neoplasms 5Pancreatic Neoplasms 4Multiple Myeloma 4HER2-positive Breast Cancer 4Urinary Bladder Neoplasms 3Prostatic Neoplasms 3Ovarian Neoplasms 3Neoplasms 3Hematologic Neoplasms 3Uterine Cervical Neoplasms 2Triple Negative Breast Neoplasms 2Salivary Gland Neoplasms 2Lymphoma 2Lung Neoplasms 2Esophageal Neoplasms 2Endometrial Neoplasms 2Wilms Tumor 1Uterine Neoplasms 1Urologic Neoplasms 1Unrespectable Locally Advanced and or Metastatic HER2 Positive Breast Cancer Participants 1Thyroid Neoplasms 1Thrombocytosis 1Solid Tumors 1Sarcoma, Synovial 1Sarcoma 1

Interventions

Magnetic Resonance Spectroscopy 5Specimen Handling 4Biopsy 3Steroids 2Hormones 2Cyclin-Dependent Kinase Inhibitor p18 2Cyclin-Dependent Kinase Inhibitor p16 2trastuzumab deruxtecan 1trastuzumab biosimilar HLX02 1taxane 1radium Ra 223 dichloride 1pertuzumab 1pembrolizumab 1naxitamab 1eicosapentaenoic acid ethyl ester 1eicosapentaenoic acid ethanolamide 1binimetinib 1abemaciclib 1X-Rays 1Vorinostat 1Trastuzumab 1Taxoids 1Taxes 1Tamoxifen 1Radiotherapy 1Radiosurgery 1Radiation 1Photons 1Paclitaxel 1PF-05280014 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Anatomic Stage IV Breast Cancer AJCC v8 × Ado-Trastuzumab Emtansine × Clear all
NCT07578116 2026-05-27

Adding Surgery and Radiation to the Usual Treatment for HER2-Positive Breast Cancer That Had Already Spread at Diagnosis

SWOG Cancer Research Network

Phase 3 Not yet recruiting
562 enrolled
Breast

Anatomic Stage IV Breast Cancer AJCC v8

Data powered by HemOnc (CC BY 4.0) Colophon âš¡